Faculty, Staff and Student Publications
Publication Date
7-15-2025
Journal
Journal of Clinical Investigation
DOI
10.1172/JCI183749
PMID
40662354
PMCID
PMC12259270
PubMedCentral® Posted Date
7-15-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Nociception involves complex signaling, yet intrinsic mechanisms bidirectionally regulating this process remain unexplored. Here, we show that the fibroblast growth factor 13 (FGF13)/Nav1.7 protein-protein interaction (PPI) complex bidirectionally modulates nociception, and that the FGF13/Nav1.7 ratio is upregulated in type 2 diabetic neuropathy (T2DN). PW164, an FGF13/Nav1.7 channel C-terminal tail domain (CTD) PPI interface inhibitor, which reduces complex assembly, selectively suppressed Na+ currents sensitized by capsaicin-induced activation of TRPV1 channels in human induced pluripotent stem cell-derived (hIPSC-derived) sensory neurons and inhibited mechanical and thermal hyperalgesia in mice. FGF13 silencing mimics PW164 activity in culture and in vivo. Conversely, ZL192, an FGF13 ligand that stabilizes FGF13/Nav1.7 CTD assembly, sensitized Na+ currents in hIPSC-derived sensory neurons and exerted pronociceptive behavioral responses in mice. ZL192's effects were abrogated by FGF13 silencing in culture and in vivo and recapitulated by FGF13 overexpression. In a model of T2DN, PW164 injection reduced mechanical hyperalgesia locally and contralaterally without systemic side effects. In donor-derived dorsal root ganglia neurons, FGF13 and Nav1.7 proteins colocalized, and the FGF13/Nav1.7 protein ratio was upregulated in patients with T2DN. Lastly, we found that SCN9A variant V1831F, associated with painless diabetic neuropathy, abolished PW164-directed modulation of the FGF13/Nav1.7 PPI interface. Thus, FGF13 is a rheostat of nociception and promising therapeutic target for diabetic neuropathy pain.
Keywords
Animals, Humans, Fibroblast Growth Factors, Mice, Sensory Receptor Cells, Diabetic Neuropathies, NAV1.7 Voltage-Gated Sodium Channel, Signal Transduction, Induced Pluripotent Stem Cells, Male, Nociception, Disease Models, Animal, TRPV Cation Channels, Female, Neuroscience, Public Health
Published Open-Access
yes
Recommended Citation
Singh, Aditya K; Bernabucci, Matteo; Dvorak, Nolan M; et al., "Sensory Neuron-Expressed FGF13 Controls Nociceptive Signaling in Diabetic Neuropathy Models" (2025). Faculty, Staff and Student Publications. 4455.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4455
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Neurosciences Commons, Oncology Commons, Public Health Commons